Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,677.56
(
-0.57%
)
US TECH 100
24,008.40
(
-0.51%
)
Dow Jones
46,576.92
(
-0.89%
)
Brent Oil
103.70
(
3.03%
)
Bitcoin
71,760.13
(
-2.95%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 842
Posts 122793
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: mcbio post# 108114

Thursday, 11/04/2010 7:52:06 PM

Thursday, November 04, 2010 7:52:06 PM

Post# of 257253
NVS/MNTA and MYL/Natco are the only ANDA filers for Copaxone, and I doubt there will be any others.

MYL is merely the US regulatory and distribution arm for the Copaxone knockoff Natco sells in India. I don’t think this drug stands a chance of getting FDA approval as a generic version of Copaxone.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now